What is Pomelo Care?
Virtual medical practice for maternal, newborn, women's, and children's health.
- Category
- Maternal and family virtual care
- Headquarters
- New York, NY
- Founded
- 2021
- Employees
- 201-500 reported range
- Total funding
- $171M disclosed from major rounds
- Valuation
- $1.7B Series C valuation
What is Pomelo Care?
Pomelo Care is a maternal and family virtual care company. Pomelo says it covers more than 25 million lives and reaches care tied to roughly 7% of U.S. births through payer and employer partnerships.
Pomelo Care is a maternal and family virtual care company with headquarters listed as New York, NY. Virtual medical practice for maternal, newborn, women's, and children's health. Pomelo says it covers more than 25 million lives and reaches care tied to roughly 7% of U.S. births through payer and employer partnerships.
The company is currently best read as Private; Series C. Public sources show $171M disclosed from major rounds in funding and $1.7B Series C valuation; where revenue, ARR, margin, or exact customer counts are not published, this profile avoids inventing them and uses funding, footprint, product coverage, and public scale signals instead.
For sellers, the account matters because buying centers span clinical operations, compliance, product, data, security, finance, and growth. The strongest pitch is tied to measurable access, quality, cost, workflow, or workforce outcomes rather than generic software adoption.
Sources:Pomelo aboutPomelo $33M
What does Pomelo Care offer?
Pomelo Care offers Pregnancy care, Postpartum care, Newborn care, Pediatric and family care expansion, and related workflows.
- Pregnancy care· Core product
- Postpartum care· Core product
- Newborn care· Care workflow
- Pediatric and family care expansion· Care workflow
- 24/7 virtual support· Expansion
- Value-based payer partnerships· Expansion
Sources:Pomelo aboutPomelo $33M
How does Pomelo Care make money?
Pomelo sells virtual value-based care to payers, employers, and risk-bearing partners, focusing on better maternal, newborn, and family outcomes with lower cost.
Pomelo sells virtual value-based care to payers, employers, and risk-bearing partners, focusing on better maternal, newborn, and family outcomes with lower cost.
Member pricing depends on plan or employer coverage; Pomelo is not a direct-to-consumer list-price clinic. Growth is driven by adoption in maternal and family virtual care, expansion into larger accounts or additional geographies, and proof that the product improves outcomes, cost, capacity, or experience.
Because the company is private, this profile does not invent revenue, gross margin, or unit economics. Sellers should qualify budget owner, reimbursement model, procurement path, compliance requirements, and integration effort early.
Sources:Pomelo aboutPomelo $33M
Who leads Pomelo Care?
Pomelo Care is led by Marta Bralic Kerns, Isabelle Von Kohorn, MD, PhD, Shyamali Choudhury, Clinical care team.
- Marta Bralic KernsFounder & CEOFounderLeads Pomelo's virtual value-based care model.
- Isabelle Von Kohorn, MD, PhDChief Medical OfficerCurrent executiveLeads clinical model and outcomes.
- Shyamali ChoudhuryChief Commercial OfficerCurrent executiveLeads payer and employer growth.
- Clinical care teamOB, pediatric, behavioral, and care navigationCurrent functionProvides multidisciplinary virtual care.
How do you contact Pomelo Care's leadership?
Pomelo Care does not publish verified personal executive emails in the reviewed public sources. Use official company contact, demo, support, partnerships, or careers routes rather than guessed personal emails.
Personal executive email format not verified; use official company routingSources:Pomelo aboutPomelo $33M
How much funding has Pomelo Care raised?
Pomelo Care has $171M disclosed from major rounds in public or reported funding; latest disclosed round: Jan 2026 Series C ($92M).
Pomelo Care's disclosed funding history is: Jun 2023 Seed/Series A: $33M, valuation not disclosed, led/backed by Andreessen Horowitz and First Round Capital; Jun 2024 Series B: $46M, valuation not disclosed, led/backed by First Round Capital and a16z Bio + Health; Jan 2026 Series C: $92M, $1.7B valuation, led/backed by Notable growth investors and existing backers.
The latest public valuation/status used here is $1.7B Series C valuation. If a valuation is not disclosed, this profile treats the company as private with no public priced mark rather than inferring a number from round size.
Seller signal: funding indicates capacity to invest, but healthcare buyers still require security, compliance, implementation proof, and outcomes evidence. New capital is most likely to support market expansion, hiring, product development, clinical operations, data, AI, and partnerships.
How did Pomelo Care get here?
Pomelo Care reached its current stage through founding, product expansion, and major financing milestones.
- 2021FoundedPomelo Care is founded to improve maternal and newborn health.
- Jun 2023$33M financingPomelo announces seed and Series A funding.
- Jun 2024$46M Series BFirst Round and a16z lead Series B.
- Jan 2026$92M Series CPomelo reaches $1.7B valuation.
- 2026Beyond maternityPomelo expands its model toward broader women's and children's healthcare.
Sources:Pomelo aboutPomelo $33M
Who are Pomelo Care's competitors?
Pomelo Care competes with adjacent healthcare providers, software platforms, marketplaces, and care-navigation companies.
- Maven ClinicEmployer and payer women's and family virtual health platform.
- OulaHybrid maternity clinic combining midwives and OBs.
- Diana HealthWomen's health practice network with hospital partners.
- BabyscriptsRemote pregnancy monitoring and maternal care platform.
- Mae HealthMaternal health platform focused on underserved mothers.
Sources:Pomelo aboutPomelo $33M
Pomelo Care — frequently asked questions
